RxDoctor Payments Data

Richard Martinez, MD

Family Medicine · Boerne, TXNPI 1295790921

Payments from drug & device makers

$1,239in general payments, 2019–2025

Across 20 payments — averaging $61.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1K
  • Novo Nordisk$47
  • AstraZeneca$40
  • Avanir Pharmaceuticals, Inc.$36
  • Sanofi-aventis U.S. LLC$22
  • AbbVie$17
  • plus $53 from 4 others

What the payments were for

  • Food & beverage$215100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,239 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$77,162
Medicare patients
246
Services billed
3,519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide101$145,718
EliquisApixaban115$106,628
JanumetSitagliptin Phos/Metformin Hcl102$97,709
MounjaroTirzepatide88$91,827
JanuviaSitagliptin Phosphate68$86,157
TrulicityDulaglutide55$50,988
GocovriAmantadine Hcl13$44,789
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$32,084
XareltoRivaroxaban16$24,810
FarxigaDapagliflozin Propanediol26$23,498
RybelsusSemaglutide19$18,603
SymbicortBudesonide/Formoterol Fumarate61$17,971
Janumet XrSitagliptin Phos/Metformin Hcl13$10,322
Spiriva RespimatTiotropium Bromide12$6,352
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$5,245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet, Januvia, Janumet Xr$1,025$194,188183 claims
Novo NordiskOzempic, Rybelsus$47$164,320120 claims
AstraZenecaFarxiga, Symbicort$40$41,46987 claims
AbbVieSynthroid$17$3,21138 claims
Sanofi-aventis U.S. LLCLantus$22$2,01019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Boerne

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →